Ita Finegan

Part of Perrigo Co. Plc, Elan Pharma International Ltd. develops, manufactures and distributes pharmaceutical products. The company is based in South San Francisco, CA.

DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark

An Post Group engages in the provision of postal, communication, retail, and financial services. The firm offers international courier services, passport express, DeliveryBox, state savings and investments, insurance services, e-Docketing, marketing services, and publication services. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Synvolux Therapeutics BV provides drug delivery services. It is specialized in transporting of DNA, RNA (siRNA and RNAi) and proteins to the target destination. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.

Organ Assist BV engages in the development of a medical device for organ preservation. It offers kidney assist transport, and donor, liver, lung, and kidney assist. The company was founded by Gerhard Rakhorst in 2005 and is headquartered in Groningen, the Netherlands.

ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands.

Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands.

Magnetar Financial (UK) LLP (Magnetar UK) is the Great Britain-based alternative investment subsidiary of Magnetar Financial LLC, itself a subsidiary of Magnetar Capital Partners LP in the US. The firm was founded by Alec Litowitz and Ross Laser in 2005. Headquartered in London, Magnetar UK provides asset management services for sophisticated clients.

The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom.

Synthon Holding BV engages in the research and production of therapeutic products. It offers remedies for cold sores, anaesthetic, hypertension, depression, neutralizing narcosis, insomnia, schizophrenia, heart failure and incontinence. The company was founded by Jacques Lemmens in 1991 and is headquartered in Nijmegen, Netherlands.

Medichem SA is a vertically Spanish integrated pharmaceutical company that specializes in the development and manufacture of APIs and FDFs for the generics market. The company is based in Sant Joan Despi, Spain, and has subsidiaries in Spain. The company offers highly potent active pharmaceutical ingredients (HPAPI) manufacturing, from development to cGMP production, and have an R & D laboratory and GMP kilo-lab. Medichem offers specific chlorhexidine transparent aqueous and alcoholic solutions based on chlorhexidine digluconate as an active ingredient, with a wide range of applications such as pharma, biocide, oral care, cosmetics, and veterinary. The company's chlorhexidine wipes are used for general disinfection. The company was founded in 1972, and José Luis Rodríguez has been the CEO of the company since 1996.

The Danish National Advanced Technology Foundation promotes research and innovation by providing funds. It offers private companies and universities the funds and the framework for developing new and important technologies. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland.

Irish Taxation Institute provides tax education to the businesses, multinationals and individuals. The company was founded on November 10, 1967 and is headquartered in Dublin, Ireland.

Vivolta BV is a world leader in the development and manufacturing of electrospun medical products. Vivolta is based in Waalre, Netherlands. The Dutch company utilizes its proprietary, fully automated medispin™ production platform to support its clients in realizing electrospun medical solutions that guide the body to heal itself. Vivolta’s medical electrospinning solutions are applicable to a broad array of high-value therapeutic areas with unmet clinical need, such as cardiovascular implants, soft tissue repair, orthopaedic sports medicine, and drug delivery. The company was founded in 2008 by Ramon Solberg, who has been the CEO since then.

VitalneXt BV develops retails and manufactures products for healthy ageing. Its products include promanna, vital01 and other products. The firm develops products with evidence-based health benefits for the ageing population. It also develops new, proprietary, technologies, ingredients and products through its own network and through collaborations with the company's research partners. The company was founded by Rein Strijker in May 2013 and is headquartered in Amersfoort, the Netherlands.

Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021.

Nutrileads BV develops food ingredi?nts with a specific nutritional value. It identifies promising lead ingredients, develops sustainable and commercially viable production processes and initiates scientific and clinical programs to test the health effects. The company was founded in 2012 by Erik Dam and Ruud Albers and is headquartered in Wageningen, the Netherlands.

Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin.

Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom.

Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark.

EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland.

Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million.

HMK Technology Group Ltd. is an investment holding British company founded in 2019. The private company is based in Congleton, UK.